Latest Reimbursement News

Gibb River Diamonds has received the crucial Mining Proposal Permit for its Neta Gold Prospect, setting the stage for mining operations to begin with equipment mobilisation planned for August 2025.

EBR Systems has won final CMS approval for New Technology Add-On Payment reimbursement, paving the way for Medicare coverage of its innovative WiSE cardiac pacing system starting October 2025.

Austal Limited has finalized a Strategic Shipbuilding Agreement with the Commonwealth of Australia, positioning its subsidiary as the nation’s key Tier 2 naval shipbuilder. This long-term pact sets the stage for significant defence vessel construction in Western Australia.

Havilah Resources has struck a binding deal with Heavy Rare Earths, granting earn-in rights to its Prospect Hill tin project with a $1.5 million exploration commitment over three years. The arrangement allows Havilah to focus on its copper assets while retaining significant upside exposure.

Rhythm Biosciences has advanced its ColoSTAT® diagnostic kits to final production validation, demonstrating consistent detection of colorectal cancer across all stages in a pivotal study. The company is gearing up for regulatory submission and commercial launch later this year.

The Star Entertainment Group has terminated its binding Heads of Agreement with joint venture partners over Brisbane and Gold Coast developments, retaining its assets but incurring significant repayment and reimbursement obligations.

Advanced Health Intelligence Ltd has locked in up to AUD 5.5 million from Oakley Capital Partners, reinforcing its capital base as it pushes toward reinstatement on the ASX and broader growth ambitions.

Tissue Repair Limited reports steady progress in its Phase 3 clinical trials for TR987® despite patient recruitment hurdles, while TR Pro+® sales surge and new distribution deals pave the way for international growth.

Gibb River Diamonds has secured a contract mining agreement for its Edjudina Gold Project, aiming to start open pit mining at the Neta Prospect by August 2025, subject to permit approvals. The deal minimizes financial risk while positioning the company to capitalise on gold production.

Solara Minerals has strengthened its foothold in Western Australia’s gold and copper sector through a major project acquisition and key executive appointments, setting the stage for upcoming drilling campaigns.

Control Bionics capped a record FY25 with 15% revenue growth, driven by US market gains and expanding NeuroNode and NeuroStrip technologies. The company also achieved a US profitability milestone and is close to finalizing key distribution partnerships.

ImpediMed Limited reported a record quarter for its SOZO device sales with $6.3 million in contracts, supported by expanded US reimbursement coverage and new funding. Despite stable revenue, the company’s cost-cutting and strategic moves position it well for growth in FY26.